Deutsche Bank reaffirmed their buy rating on shares of Monsanto (NYSE:MON) in a research report report published on Tuesday.

Other analysts also recently issued research reports about the company. Royal Bank of Canada reiterated a hold rating and issued a $128.00 price objective on shares of Monsanto in a research report on Wednesday, November 15th. Wells Fargo & Co boosted their price objective on Monsanto from $107.50 to $118.00 and gave the company a market perform rating in a research report on Tuesday, October 10th. Macquarie downgraded Monsanto from an outperform rating to a neutral rating in a research report on Wednesday, October 4th. Barclays reiterated an equal weight rating and issued a $124.00 price objective (up previously from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Finally, BMO Capital Markets reiterated a buy rating and issued a $128.00 price objective on shares of Monsanto in a research report on Thursday, October 5th. Eleven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus target price of $127.30.

Shares of Monsanto (NYSE:MON) traded up $0.02 during mid-day trading on Tuesday, reaching $119.72. The company’s stock had a trading volume of 4,182,100 shares, compared to its average volume of 3,713,240. The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 1.05. Monsanto has a 12-month low of $106.97 and a 12-month high of $122.79. The company has a market capitalization of $52,300.00, a P/E ratio of 22.13, a P/E/G ratio of 1.71 and a beta of 1.04.

Monsanto (NYSE:MON) last announced its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The company had revenue of $2.66 billion during the quarter, compared to the consensus estimate of $2.77 billion. During the same quarter in the previous year, the firm posted $0.21 EPS. The business’s revenue for the quarter was up .3% compared to the same quarter last year. equities analysts forecast that Monsanto will post 5.76 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be issued a dividend of $0.54 per share. The ex-dividend date is Thursday, January 4th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.80%. Monsanto’s dividend payout ratio is presently 39.93%.

In related news, EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the sale, the executive vice president now directly owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Pierre Courduroux sold 4,320 shares of the company’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the completion of the sale, the chief financial officer now directly owns 48,388 shares in the company, valued at $5,903,336. The disclosure for this sale can be found here. 0.70% of the stock is owned by corporate insiders.

Hedge funds have recently modified their holdings of the stock. Bruderman Asset Management LLC purchased a new stake in Monsanto in the second quarter worth $116,000. Tower Research Capital LLC TRC grew its stake in shares of Monsanto by 230.1% in the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after acquiring an additional 750 shares during the last quarter. Americafirst Capital Management LLC purchased a new stake in shares of Monsanto in the third quarter worth $148,000. Fieldpoint Private Securities LLC grew its stake in shares of Monsanto by 100.6% in the second quarter. Fieldpoint Private Securities LLC now owns 1,575 shares of the basic materials company’s stock worth $186,000 after acquiring an additional 790 shares during the last quarter. Finally, Loews Corp purchased a new stake in shares of Monsanto in the second quarter worth $202,000. 75.37% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Deutsche Bank Reaffirms “Buy” Rating for Monsanto (MON)” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2018/01/17/deutsche-bank-reaffirms-buy-rating-for-monsanto-mon.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Analyst Recommendations for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related stocks with our FREE daily email newsletter.